WEST LAFAYETTE, Ind. (AP) — An Indiana biotechnology company has won $200,000 in federal funding to boost its technology that could help more quickly determine which drugs may help cancer patients.
The National Cancer Institute awarded West Lafayette-based KinaSense the grant to refine technology that’s based on Purdue University intellectual property.
KinaSense co-founder Steve Ouellette says the grant will help the company begin laboratory operations and is a validation of its vision and technology.
He calls the federal funding a major milestone toward realizing the startup company’s “mission to help save lives in the battle against cancer.”
KinaSense’s technology could help researchers and oncologists see faster than ever before which drug therapies will benefit cancer patients and to what extent.